Ignite Creation Date:
2024-05-06 @ 8:17 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06327100
Status:
RECRUITING
Last Update Posted:
2024-05-03
First Post:
2024-03-15
Brief Title:
Open Label Phase 2 Study of Tasquinimod in Patients With Primary Myelofibrosis PMF Post-Polycythemia Vera Myelofibrosis Post-PV MF or Post-Essential Thrombocytosis Myelofibrosis Post-ET MF
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Organization Data
Organization:
MD Anderson Cancer Center
Class:
OTHER
Study ID:
2023-0934
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
MD Anderson Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Active Biotech AB | INDUSTRY |